Announcement

KOBAYASHI Healthcare (Thailand) Co., Ltd. is announcing the following release on behalf of KOBAYASHI Pharmaceutical Co., Ltd. for the customers in Thailand.

Date: 22 March, 2024

To Whom It May Concern:

Request for discontinuation of use of「Beni-koji」related products and notice of voluntary recall by KOBAYASHI Pharmaceutical Co., Ltd.

KOBAYASHI Pharmaceutical Co., Ltd. (Head office: Osaka, Japan; President: Akihiro Kobayashi) has received a report that kidney problems have occurred in those who consumed 「Beni-koji Cholestehelp」, a foods with functional claims marketed by us. In response, we conducted an ingredient analysis of this product and the「Beni-koji」ingredients used in it (manufactured by us) where we found that some of the「Beni-koji」ingredients may contain components that we did not anticipate.

At this point in time, we have not been able to identify the exact ingredient nor have we been able to clearly identify the causal relationship between this product and experiencing kidney problems. However, as a precautionary measure to prevent the spread of health hazards to our customers, we have decided to voluntarily recall the「Beni-koji」related products listed below as Subject Products.

We deeply apologize for any inconvenience this may cause to our customers and other concerned parties. We consider this to be a serious matter and will continue to investigate.

<Request to our Customers in Thailand>
For customers who have any of the Subject Products listed, we ask that you please discontinue the use of the product and refrain from consuming it in the future. In addition, for customers who have consumed the Subject Products and feel any physical discomfort, please contact us. (KOBAYASHI is not selling these products in Thailand.)

■ Subject Products

■ Non-subject products